Evaluate Bioequivalence of Burotam (1/1 g/Vial)

NCT05654090 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Infectious Diseases

Interventions

DRUG: cefoperazone sodium and sulbactam sodium

Sponsor

Yung Shin Pharm. Ind. Co., Ltd.